Citadel Advisors’s Immatics IMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-109,200
Closed -$492K 13721
2025
Q1
$492K Sell
109,200
-185,100
-63% -$966K ﹤0.01% 8511
2024
Q4
$2.09M Buy
294,300
+122,500
+71% +$1.05M ﹤0.01% 5532
2024
Q3
$1.96M Buy
171,800
+81,200
+90% +$961K ﹤0.01% 5572
2024
Q2
$1.05M Buy
90,600
+43,500
+92% +$490K ﹤0.01% 6478
2024
Q1
$495K Sell
47,100
-10,400
-18% -$121K ﹤0.01% 8426
2023
Q4
$605K Sell
57,500
-53,100
-48% -$489K ﹤0.01% 7683
2023
Q3
$1.28M Buy
110,600
+108,700
+5,721% +$1.3M ﹤0.01% 6071
2023
Q2
$21.9K Sell
1,900
-700
-27% -$6.53K ﹤0.01% 12648
2023
Q1
$17.9K Sell
2,600
-3,500
-57% -$28.6K ﹤0.01% 13140
2022
Q4
$53.1K Buy
+6,100
New +$63.1K ﹤0.01% 12044
2022
Q3
Sell
-10,100
Closed -$88K 13079
2022
Q2
$88K Buy
+10,100
New +$79.9K ﹤0.01% 11523

Other funds holding IMTX

Citadel Advisors's IMTX Position: Q2 2026 in Review

Citadel Advisors reduced its Immatics (IMTX) stake by 2% in Q2 2026, selling an estimated $394K and leaving 1,814,657 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2694.

Citadel Advisors first reported a position in IMTX in Q2 2021 and has held it in 19 quarters since. The position peaked at $21.9M in Q3 2024. 82 funds tracked by Wall St. Rank hold IMTX as of Q2 2026.

  • Citadel Advisors held 1,814,657 shares of Immatics worth $18.4M as of Q2 2026.
  • Citadel Advisors sold 37,306 Immatics shares in Q2 2026, an estimated $394K.
  • Immatics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2694 holding.
  • Citadel Advisors first reported a position in Immatics in Q2 2021 and has held it in 19 quarters since.
  • Citadel Advisors's Immatics position peaked at $21.9M in Q3 2024.
  • 82 funds tracked by Wall St. Rank held Immatics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.